Cambridge, MA, United States of America

Sergio Andre Rodriguez Aponte

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergio Andre Rodriguez Aponte. Retrieved from https://idiyas.com/inventor/sergio-andre-rodriguez-aponte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sergio Andre Rodriguez Aponte

Introduction

Sergio Andre Rodriguez Aponte is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of immunology, particularly in relation to coronaviruses. His work focuses on enhancing the effectiveness of vaccines through innovative approaches.

Latest Patents

Rodriguez Aponte holds a patent for "SARS-CoV-2 antigens and uses thereof." This patent relates to variants of the receptor binding domain of a coronavirus, specifically SARS-CoV-2. These variants exhibit increased immunogenicity and reduced aggregation, which can be utilized in methods for preventing coronavirus infections.

Career Highlights

Rodriguez Aponte is affiliated with the Massachusetts Institute of Technology, where he engages in cutting-edge research. His work is pivotal in the ongoing efforts to combat viral infections and improve public health outcomes.

Collaborations

He has collaborated with notable colleagues, including J Christopher Love and Neil Chandra Dalvie, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sergio Andre Rodriguez Aponte's contributions to the field of immunology and his innovative patent on SARS-CoV-2 antigens highlight his role as a key figure in the fight against viral infections. His work continues to inspire advancements in vaccine development and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…